CHF 40,000 for AI to improve the healthcare system streamlined literature review, a platform to coordinate space traffic, and single-protein sensors
21.11.2024
Intonate, Spacetalk, Unomr were selected at Venture Kick's second financial and entrepreneurial support stage. Their projects enable the data protection-compliant recording of consultations between doctors and their patients; offer a digital platform for all space actors worldwide, providing operational points of contact for all space objects; and develop a sensor technology enabling protein modification-related diseases like cancer to be diagnosed years before symptoms.
 |
 |
 Intonate: COO Tim Gmünder, CEO Julian Sutter, and CTO Livio Schlaepfer
|
|
 Spacetalk, from left to right: CCO Jérôme Bontron, CSO Elisabeth Tripod-Fatio, CTO Michel Fischer and CEO Dr. Benjamin Guyot
|
|
 Unomr: CTO Julian Hengsteler, COO Julia Wagner, and CEO Til Schlotter
|
|
Intonate: Responsibly leveraging AI to improve the healthcare system.
The excessive documentation burden on doctors today leads to decreased job satisfaction and burnout, negatively impacting patient care.
Intonate enables the data protection-compliant recording of consultations between doctors and their patients, including those in Swiss German. Based on the relevant information provided in the recording, the AI-powered technology automatically generates a structured medical report suggestion within seconds. The global size of the market is estimated at CHF 15.5 billion, with the Swiss market estimated at CHF 500 million. The startup primarily focuses on the outpatient sector, and its software is already being used in several general practices and by specialists. Intonate's founding team is highly diverse, comprising a doctor and two graduates from ETH Zürich - one with a Master's in Computer Science and the other with a Master's in MTEC.
The Venture Kick fund will contribute to a pilot project that assesses the technology’s precision in processing different Swiss German dialects.
Spacetalk: The neutral platform for coordinating space traffic among all space actors worldwide
The increasing number of satellites and space debris are crowding Earth's orbit. The lack of a unified space traffic coordination system endangers satellites and increases operational costs due to more frequent collision avoidance maneuvers.
Spacetalk's founders and board members team includes a space law expert, an IT engineer with extensive experience, an entrepreneur with a broad network in the public sector, and a design engineer who is a seasoned entrepreneur. They are supported by an advisory board of experienced space sector representatives.
Spacetalk offers a digital platform for all space actors worldwide, providing operational points of contact for all space objects. It targets a worldwide market of approximately 900 customers and a space situational awareness market valued at about USD 1.7 billion in 2023, with a CAGR of around 4.6%.
The Venture Kick funds will be used for the company’s commercial development and to support the fundraising process for developing the platform MVP.
Unomr: Single-protein sensors to revolutionize medical development.
Medical advancements are limited as the ability of analytical instruments to measure modifications of proteins and the sequence of single proteins is limited. Based on Unomr’s sensor technology, the pharma industry will identify new drug targets, biotech companies can improve their cell line development, and protein modification-related diseases like cancer will be diagnosed years in advance of symptoms.
Unomr is a spin-off of ETH Zurich and is co-founded by Dr. Til Schlotter (CEO), Dr. Julia Wagner (advisory COO), and Julian Hengsteler (CTO). During their PhDs, Til and Julian developed the underlying interface nanopore sensor technology and currently focus on the application development and scale-up of the sensor. Julia holds a PhD in mathematics, has deep tech VC experience, and advises on operations, fundraising, and legal topics.
Protein characterization and identification represents a global market of USD 15 billion annually and is expected to reach more than USD 30 billion by 2030.
The Venture Kick funds will contribute to the business model validation, customer acquisition, and prototype improvements allowing Unomr to provide a protein modification analysis service to first customers.
The excessive documentation burden on doctors today leads to decreased job satisfaction and burnout, negatively impacting patient care.
Intonate enables the data protection-compliant recording of consultations between doctors and their patients, including those in Swiss German. Based on the relevant information provided in the recording, the AI-powered technology automatically generates a structured medical report suggestion within seconds. The global size of the market is estimated at CHF 15.5 billion, with the Swiss market estimated at CHF 500 million. The startup primarily focuses on the outpatient sector, and its software is already being used in several general practices and by specialists. Intonate's founding team is highly diverse, comprising a doctor and two graduates from ETH Zürich - one with a Master's in Computer Science and the other with a Master's in MTEC.
The Venture Kick fund will contribute to a pilot project that assesses the technology’s precision in processing different Swiss German dialects.
Spacetalk: The neutral platform for coordinating space traffic among all space actors worldwide
The increasing number of satellites and space debris are crowding Earth's orbit. The lack of a unified space traffic coordination system endangers satellites and increases operational costs due to more frequent collision avoidance maneuvers.
Spacetalk's founders and board members team includes a space law expert, an IT engineer with extensive experience, an entrepreneur with a broad network in the public sector, and a design engineer who is a seasoned entrepreneur. They are supported by an advisory board of experienced space sector representatives.
Spacetalk offers a digital platform for all space actors worldwide, providing operational points of contact for all space objects. It targets a worldwide market of approximately 900 customers and a space situational awareness market valued at about USD 1.7 billion in 2023, with a CAGR of around 4.6%.
The Venture Kick funds will be used for the company’s commercial development and to support the fundraising process for developing the platform MVP.
Unomr: Single-protein sensors to revolutionize medical development.
Medical advancements are limited as the ability of analytical instruments to measure modifications of proteins and the sequence of single proteins is limited. Based on Unomr’s sensor technology, the pharma industry will identify new drug targets, biotech companies can improve their cell line development, and protein modification-related diseases like cancer will be diagnosed years in advance of symptoms.
Unomr is a spin-off of ETH Zurich and is co-founded by Dr. Til Schlotter (CEO), Dr. Julia Wagner (advisory COO), and Julian Hengsteler (CTO). During their PhDs, Til and Julian developed the underlying interface nanopore sensor technology and currently focus on the application development and scale-up of the sensor. Julia holds a PhD in mathematics, has deep tech VC experience, and advises on operations, fundraising, and legal topics.
Protein characterization and identification represents a global market of USD 15 billion annually and is expected to reach more than USD 30 billion by 2030.
The Venture Kick funds will contribute to the business model validation, customer acquisition, and prototype improvements allowing Unomr to provide a protein modification analysis service to first customers.